A participant in AstraZeneca's coronavirus vaccine trial in Brazil has died, marking the first death in a COVID-19 vaccine trial.
The 28-year-old man ...
You are unauthorized to view this page. For access, please become a member.
The plan is to saturate the digital space with low-risk US artificial intelligence models, fast-track data center construction, and secure high-risk AI projects.